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Purpose 
Caffeine is a psychostimulant commonly used to alleviate drowsiness and increase 
alertness. Almost everyone consumes caffeine on a daily basis through drinks (e.g., coffee, tea 
and energy drinks), food (mainly chocolate), or medications such as diet pills and migraine 
treatments (Nehlig, 2010). Because caffeine is widely viewed as safe, it is commonly used at 
relatively high levels among college students to enhance academic performance and cope with 
the stress of their workload (Kalash and Tannous, 2014). It has long been known that high 
caffeine consumption produces the condition of caffeinism, which most often presents as an 
anxiety disorder (MacKay and Rollins, 1989; Strous, 2006; Hedges, Woon and Hoopes, 2009; 
Roy-Byrne, 2015).  Even moderate to low doses can exacerbate existing psychological disorders 
(e.g., Benke, Blumenthal, Mode, Hamm and Pané-Farré, 2015). Therefore, given these risks to 
mental health and that 68.5% of WSU students report using moderate to heavy doses of caffeine 
to enhance academic performance, it has become increasingly important to determine whether 
the perceived cognitive enhancing benefits of caffeine use outweigh the risks to mental health 
(Fitzgerald, Glavanovich, Howes, and Krzyanowski, 2010; Garlick, and Luebke, 2013). 
Nehlig (2010) reviewed caffeine’s effects on learning and found that 64% of those 
studies reported that caffeine had no effect on performance, 24% of the studies showed caffeine-
induced improved free recall and 12% of studies observed caffeine impaired recall.  There are 
several possible explanations for a lack of consensus on caffeine’s behavioral effects. 
First, it has been impossible to obtain a pure control group (i.e., never used or not 
currently using caffeine) for human studies of caffeine’s psychotropic effects due to its 
widespread use.  In my review of the literature, I was unable to find a single study with a true 
control group. Researchers commonly use overnight abstinence of caffeine prior to testing to 
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create the control group, however, the problem is that overnight abstinence follows 
approximately the same time frame (10-14 h) in which withdrawal symptoms appear. So any 
reported benefit of caffeine in studies using this design could mainly be due to the reversal of 
aversive withdrawal symptoms such as: fatigue, difficulty concentrating, decreased energy and 
headache (James and Rogers, 2005). Second, caffeine has a relatively fast half-life (2.5-4.5 h) 
but it would still be expected to be in the system for up to 48 hours suggesting that some heavy 
users may still be defined as caffeine treated even after overnight abstinence. Finally, none of the 
studies reviewed tested for caffeine levels in the participants but rather used self-report which is 
likely to produce inaccuracy. These three factors alone question the validity of the control group 
most commonly used in human caffeine research. This observation led me to design a pilot study 
in preparation for this grant application in which I replicated the traditional caffeine study with 
two changes.  First, I obtained saliva samples before and after caffeine consumption in both 
controls and caffeine treated participants and determined salivary caffeine levels. Second, 
participants were tested twice so that they served in both the caffeine and control groups to 
control for differences in rates of caffeine metabolism. 
I hypothesized that 46 mg of caffeine (found in a single can of diet Coke) would improve 
college students’ learning and memory during free recall testing after abstaining from caffeine 
for 12 h. Over the course of 48 hours, using a within-subjects, double blind design, I gave nine 
Winona State students either caffeinated diet Coke (46 mg) or caffeine free Coke zero 30 
minutes prior to free recall testing. On both test days, saliva samples were taken prior to 
beverage consumption to determine if participants abstained from caffeine 12 h before testing as 
instructed. Participants consumed their beverage, waited 30 minutes for the caffeine to take 
effect, and then completed five trials of a free recall test. The test consisted of 25 words 
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individually displayed on the computer screen for 1 s. A 20 s delay was imposed between the 
presentation of the last word and the actual recall test. Participants were then given 60 seconds to 
type as many of the words that they could remember. A second saliva sample was collected after 
the participants completed the fifth trial. An ELISA was completed on the saliva samples to 
determine the participant’s actual salivary caffeine levels. To test whether or not learning 
occurred, I calculated a difference score by subtracting the number of words correctly recalled 
during trial one from trial five.  
I found a curvilinear correlation between salivary caffeine and free recall.  Specifically, 
caffeine concentrations less than approximately 1500 ppb showed a positive correlation, 
suggesting that 46 mg of caffeine may be enough to show significant improvement in 
performance during free recall testing. Additionally, caffeine concentrations between 1500 and 
2000 ppb impaired recall. These pilot data suggest a dose-dependent relationship between 
caffeine and memory in college students, however, only one participant arrived completely 
caffeine free even though all students reported abstaining from caffeine.  This means, like 
previous studies, my control group was also confounded. Therefore, the method of using 
overnight abstinence as a control group is inappropriate and a different research design is 
required to determine caffeine’s psychotropic actions. Therefore, the purpose of the experiment 
outlined in this proposal was to use a true caffeine free control group in order to evaluate the 
effects of caffeine use on learning and memory as well as determine whether cognitive 
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Eighteen participants were recruited from upper level psychology courses and randomly 
assigned to either the experimental group (receiving 46 mg of caffeine from a 12 oz. diet Coke) 
or the control group (12 oz. of caffeine free Coke Zero). Persons taking anxiolytics, 
antidepressants, neuroleptics, mood stabilizers or migraine medications were excluded to control 
for potential drug interactions as each of these drugs can change the net dose of caffeine by 
altering its metabolism. 
Materials and Procedures 
A laptop equipped with the testing software developed in-house was used. Over the 
course of eight days, saliva samples, self-evaluations of withdrawal symptoms and physiological 
and psychological measures of anxiety were collected and recorded using the protocol outlined 
in Table 1. Days zero through four used self-evaluations to record withdrawal symptoms 
participants experienced during caffeine abstinence. On day five, test day, each participant 
received 12 oz. of the assigned beverage, waited 30 minutes for the beverage to take effect, and 
then completed a test of learning and memory. Oximeters and self-evaluations were used to 
record both physiological and psychological symptoms of anxiety post beverage consumption on 
days five through eight. 
 On the test day, a practice trial was completed to familiarize participants with the testing 
procedure. Participants then completed five trials each consisting of the presentation of the same 
25 words individually shown for 1 s followed by a 20 s delay during which participants were 
required to memorize the words. Participants were then allowed 60 s to type as many words as 
they could remember. To determine at what rate each participant metabolizes caffeine, the 
researcher collected additional saliva samples at the following times post test: 2 h, 4 h, 24 h, 48 h 
and 72 h. Once all of the data was collected, the researcher completed a caffeine ELISA kit to 
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test salivary caffeine levels at day zero, day one, day five (pre-treatment, +45 minutes, +2 hours, 
+4 hours), +24 hours and +48 hours for all participants. 
Table 1. Summary of Research Protocol 
Day Saliva Collection/ 
Symptom Assessment 
Day Saliva Collection/ 
Symptom Assessment 
0 Initial collection, commit to 
abstinence 
5b. Post-memory test sample (45 mins) 
1 24 h abstained 5c. Post-test sample (2 h) 
2 48 h abstained 5d. Post-test sample (4 h) 
3 72 h abstained 6 Post-test sample (24 h) 
4 96 h abstained 7 Post-test sample (48 h) 
5 Memory Test Day 
120 h abstained/Pre-beverage sample 




Figure 1 A illustrates the mean salivary caffeine levels at day zero and at day five. As 
predicted, salivary caffeine levels changed significantly from day zero to day five, F(1, 14) = 
10.428, p < .01. However, gender did not significantly effect salivary caffeine levels F(1, 14) = 
.010, p = .922. Figure 1 B illustrates the mean salivary caffeine levels at day zero and day one. 
When analyzing if drug condition and gender had an effect on pulse at 120 hours abstained (day 
five) and 45 minutes post-drug treatment, the results were as follows. Drug condition did not 
significantly effect pulse at 120 hours abstained (F(1, 14) = 3.918, p = .068). However, caffeine 
significantly reduced pulse at 45 minutes post-treatment, (F(1, 14) = 9.518, p = .008). 
Additionally, gender did not significantly effect pulse at both 120 hours abstained, (F(1, 14) = 
3.712, p = .075) and 45 minutes post-drug treatment (F(1,14) = 4.196, p = .060). Lastly, there is 
no significant interaction effect of drug condition and gender for pulse at 120 hours abstained, 
(F(1,14) = .034, p = .989) and at 45 minutes post-drug treatment, (F(1,14) = .163, p = .970). 
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When analyzing intoxication scores at baseline (day 0), no significant effect was found 
for either drug condition, (F(1, 10) = .005, p = .943) or gender (F(1, 10) = 2.119, p = .176). Also, 
there is no significant interaction between drug condition and gender, (F(1, 10) = .339, p = .573). 
These results suggest that intoxication scores at baseline were not influenced by the drug 
condition assigned or gender. Acquisition did change significantly from trial one to trial five, 
(F(1, 14) = 136.175, p = .000). However, caffeine treatment did not significantly effect 
acquisition (F(1, 14) = 1.623, p = .223) nor was there a significant gender effect (F(1, 14) = 
3.897, p = .060). Memory retention did not change significantly over time (2, 4, 24 and 48 hours) 
after the memory test (F(1, 14) = .323, p = .579). Additionally, caffeine treatment did not 
significantly effect retention, (F(1, 14) = 3.896, p = .068) nor was there a significant gender 
effect (F(1, 14) = 2.768, p = .118). Withdrawal ratings did not change significantly over time (2, 
4, 24 or 48 hours after treatment); F(1, 14) = 1.524, p = .237). Additionally, caffeine treatment 
did not significantly effect withdrawal ratings (F(1, 14) = 1.581, p = .229) nor was there a 
significant gender effect (F(1, 14) = .806, p = .384). 
Discussion 
 The purpose of this experiment was to use a true caffeine free control group in order to 
evaluate the effects of caffeine use on learning and memory as well as determine whether 
cognitive enhancing benefits can be obtained without the potential for adverse psychotropic 
effects such as anxiety. The present study showed that participants still had significant amounts 
of caffeine in their systems after 24 hours of abstinence (more than double the abstinence period 
used in prior studies).  The data also showed that all participants in the present study had salivary 
caffeine levels reduced to zero after five days. Prior to the completion of the current study, most 
caffeine research used overnight abstinence as a research design, but the data found in this study 
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(see Figure 1) clearly demonstrates that overnight abstinence is an inappropriate method and a 
five-day washout, as used in our study, is required to obtain a true control group for studies 
testing the effects of caffeine. Unfortunately, these data seriously call into question the validity 
of most if not all previous caffeine research with human participants.  
Although we successfully reached our initial object of testing at least 20 subjects, we 
have elected to continue running additional participants to improve several aspects of our study. 
First, there were not enough male volunteers (n=4) who participated in this study to fully 
evaluate possible gender effects. Therefore, one of our goals moving forward with this study will 
be to increase the number of male participants. Additionally, a number of our female participants 
reported using oral contraceptives, which research shows can affect the metabolism rate of 
caffeine. At present we do not have enough female participants using the various forms of 
contraception to fully control for possible confounding effects of these drugs on caffeine 
metabolism. Thus, our second goal this fall will be to control for the effects of different methods 
of birth control (i.e. oral, injection, subdural) on caffeine metabolism by specifically recruiting 
females from these subgroups. Our plan will be to continue running participants throughout the 
summer of 2016 through fall semester 2016. We recently submitted a request to the WSU IRB to 
extend testing and approval was granted on 5-11-16.   
If accepted, we plan to disseminate the preliminary data collected through May 10, 2016 
at the annual Midbrains Neuroscience Research Conference in October 2016.  When all of the 
subgroups are adequately represented we plan to submit the paper for consideration for 
publication.  Copies will be made available.  We wish to thank WSU Research Grant fund. 
  
  
























Figure 1. Summary of the mean salivary caffeine levels at A) baseline and pre-memory test, and 
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Final Budget 
Item(s) Amount 
Data Analysis:  
ELISA kits (3 x $500 each) 11/05/15 - $570.00 
  
Testing Supplies:  
Diet Coke and Coke Zero $30.00 
 Plastic Cups 
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